These results highlight the need for a more detailed investigation into the molecular mechanisms of WT1-driven fibroblast activation and pulmonary fibrosis and whether the crosstalk between WT1 and the TGFβ/SMAD pathway regulates them. The gene discussed is WT1; the disease is pulmonary fibrosis.